Scientific and Technological Prospecting of 1H-1,2,3-Triazoles

The use of 1H-1,2,3-triazoles has become an important scaffold for applications in different technological sectors. Therefore, we sought to carry out technological monitoring to understand the international scenario involving 1H-1,2,3-triazoles from the patents filed, in addition to evaluating the relationship between the growth in the number of patents and the improvement of strategies for obtaining these compounds via a metal-catalyzed azide-alkyne cycloaddition reaction. Technological monitoring was performed with the support of the PatentInspiration (R) platform, using the keywords 1.2.3-triazol, 1,2,3-triazole, and 1.2,3-triazolyl. A total of 960 registered patents were found, most for the years 2014 and 2019. The main filers were prestigious multinational companies, such as Syngenta, Merck, Sandoz, Pfizer, and Bayer. The United States, China, Japan. and Germany lead patent registrations, mainly addressing innovations in chemistry and metallurgy, human needs, and new technologies. These results help to understand the state of innovation for this topic, pointing out the characteristics of the main discoveries concerning 1H-1,2,3-triazole derivatives.

Automated summary

The use of 1H-1,2,3-triazoles has become an important scaffold in various technological sectors. This study conducted technological monitoring to understand the international scenario of 1H-1,2,3-triazoles based on filed patents, and examined the relationship between the number of patents and improved strategies for obtaining these compounds. The analysis revealed significant patent filings by prestigious multinational companies and identified the countries leading in patent registrations.